Medinotec Inc.
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, … Read more
Medinotec Inc. (MDNC) - Total Assets
Latest total assets as of November 2025: $6.85 Million USD
Based on the latest financial reports, Medinotec Inc. (MDNC) holds total assets worth $6.85 Million USD as of November 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medinotec Inc. - Total Assets Trend (2022–2025)
This chart illustrates how Medinotec Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medinotec Inc. - Asset Composition Analysis
Current Asset Composition (February 2025)
Medinotec Inc.'s total assets of $6.85 Million consist of 94.3% current assets and 5.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 40.7% |
| Accounts Receivable | $2.61 Million | 38.4% |
| Inventory | $988.34K | 14.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how Medinotec Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medinotec Inc.'s current assets represent 94.3% of total assets in 2025, an increase from 0.8% in 2022.
- Cash Position: Cash and equivalents constituted 40.7% of total assets in 2025, up from 10.0% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 38.4% of total assets.
Medinotec Inc. Competitors by Total Assets
Key competitors of Medinotec Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Medinotec Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Medinotec Inc. generates 1.34x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Medinotec Inc. generates $ 31.72 in net profit.
Medinotec Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.79 | 3.34 | 22.00 |
| Quick Ratio | 3.89 | 2.56 | 18.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.12 Million | $ 3.45 Million | $ 3.75 Million |
Medinotec Inc. - Advanced Valuation Insights
This section examines the relationship between Medinotec Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.74 |
| Latest Market Cap to Assets Ratio | 1.33 |
| Asset Growth Rate (YoY) | 41.7% |
| Total Assets | $6.81 Million |
| Market Capitalization | $9.06 Million USD |
Valuation Analysis
Above Book Valuation: The market values Medinotec Inc.'s assets above their book value (1.33 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Medinotec Inc.'s assets grew by 41.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medinotec Inc. (2022–2025)
The table below shows the annual total assets of Medinotec Inc. from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-02-28 | $6.81 Million | +41.73% |
| 2024-02-29 | $4.80 Million | +6.99% |
| 2023-02-28 | $4.49 Million | +239.40% |
| 2022-02-28 | $1.32 Million | -- |